Abstract: Nerve growth factor (NGF) is a potent inducer of cell proliferation through autophosphorylation of its high-affinity receptor (trkA). Estrogen also modulates proliferation of cells expressing estrogen receptors (ER). Our previous work showed that urothelial cells express both ER α and ER β , and that trkA, NGF, ER α and ER β coexist within bladder mucosa. In this report, we examined interaction between estrogen and NGF relative to cell proliferation using primary cultures of human urothelial cells (HUC). 17β-estradiol (E 2 , 50 nM), an ER α agonist (16α-iodo-17β-estradiol, 16IE 2, 10 nM) and an ER β agonist (genistein, 50 nM ) all stimulated HUC proliferation. These effects were abolished by the estrogen antagonist ICI 182, 780 (100nM). NGF (1-100 ng/ml) also stimulated HUC proliferation, and this effect was abolished by NGF-antiserum (0.1µl/ml) or a trkA antagonist (K252a, 100 nM). HUC proliferation stimulated by E 2 was also abolished by NGF-antiserum or K252a. Furthermore, we found E 2 stimulated NGF synthesis in HUC, and this effect was inhibited by ICI 182, 780. Immunocytochemical staining and immunoblotting confirmed the expression of ER α , ER β , and NGF receptors in HUC.
NERVE GROWTH FACTOR (NGF) is not only a classical target-derived
neurotrophic factor that is important in the development and maintenance of the peripheral and central nervous systems, it is also involved in growth and differentiation of a wide variety of tissues. For example, NGF has been demonstrated to be associated with an autocrine action which affects the proliferation of bladder smooth muscle cells (39) and corneal epithelial cells (27) . Previous studies using PC12 cells provided evidence that the majority of effects of NGF are mediated by binding to its high-affinity receptor, tyrosine kinase A (trkA), which induces trkA dimerization and autophosphorylation (20, 21, 22 ). An alkaloid-like compound, K252a, has been demonstrated to be a specific inhibitor of NGF-induced phosphorylation of trkA (5) . Recently, Rende et al reported that exogenous NGF increased proliferation of normal myogenic cells but not cells lacking trkA (38) . Moreover, NGF over-expressing keratinocytes proliferated more rapidly than mock-transfected cells (37) . In both cases, K252a blocked NGF-induced cell proliferation.
It has also been reported that estrogen enhances the proliferation of several cell types, including epithelial cells (2) . Two primary subtypes of estrogen receptors (ER), ER α and ER β , have been identified to date, and these receptors appear to play an important role in the estrogen-induced epithelial response (25). Intrahepatic biliary epithelial cells express both ER α and ER β , and estrogen stimulates proliferation of these cells in vivo and in vitro, an effect blocked by ICI 182,780, a specific antagonist of both ER subtypes (1) . Buchanan et al also demonstrated that estrogen-stimulated vaginal epithelial proliferation was eliminated by ICI 182,780 and was not observed in ER α knock-out mice (10) .
Epithelial cells lining the urinary tract also express both ER α and ER β (7). Increased NGF was observed in the mucosa of bladder biopsies obtained from female patients with painful bladder disorders as well as in the urine of intersitial cystitis and bladder cancer patients (31,34). It has been hypothesized that estrogen and NGF act synergistically by cross-talk between receptors (43) . However, interaction between estrogen and NGF in urothelium is poorly understood. Recently, we observed that trkA, p75, NGF, ER α , and ER β coexist within the bladder mucosa (8) . The current study was undertaken to investigate interactions among estrogen, NGF, and proliferation of human urothelial cells (HUC) . We used primary cultures of HUC to evaluate the effect of 17β-estradiol (E 2 ), as well as two other specific agonists of ER α and ER β , and recombinant human NGF (rhNGF), on proliferation of HUC. We also used NGF-antiserum, an estrogen antagonist (ICI 182,780) and an antagonist of trkA (K252a) to investigate interaction of estrogen and NGF relative to HUC proliferation. Our data indicate that the effects of ER activation on HUC proliferation at least partly involve modulation by NGF via its high-affinity receptor, trkA.
METHODS
Primary HUC culture. All experimental protocol were reviewed and approved by the Health Sciences Human Subjects Committee of the University of Wisconsin. Ureter segments near the ureterovesical junction were obtained from healthy donors as byproducts of kidney transplant surgery. The mucosal layer was dissected from the underlying stroma, the urothelium was cut into 1 mm 2 explants, and the explants were plated on 100 mm petri plates coated with type I rat-tail collagen gel substrate. The medium used was phenol-red free Ham's F12 (GIBCO, Grand Island, NY) supplemented with 0.1 µg/ml hydrocortisone, 5 µg/ml transferin, 10 µg/ml insulin, 0.1 mM nonessential amino acid, 27 mg/ml dextrose, 2.0 mM L-glutamine, 100 u/ml penicillin, 100 µg/ml streptomycin, and 1 % charcoal-stripped fetal bovine serum (Sigma, St. Louis, MO) (F12+). Cultures were placed in a humidified incubator at 37°C in 5% CO 2 . Cells were dispersed for subculture after a 10-minute incubation at 37°C in 0.05% trypsin-EDTA.
Cell number and percent viability were determined by examining singly dispersed cell samples stained for 5 minutes with 0.1% trypan blue stain (Sigma). Cells were used between 3 to 5 passages. Tissues used were obtained from 2 male and 1 female donors.
Data reported here were generated using replicates of cells obtained from the same donor to allow performance of contemporaneous studies. Studies were repeated 3 times, results
were consistent regardless of the source of cells, and results reported are representative of experiments performed. In this study and preliminary experiments, no gender difference was observed among the responses.
AlamarBlue assay for cell proliferation. HUC were plated onto 96-well tissue culture plates at an initial density of 500 cells per well and incubated at 37 °C overnight.
The medium was changed to F12 mixture (without any other supplements except 100 u/ml penicillin, 100 µg/ml streptomycin) containing 5% almarBlue (TREK Diagnostic Systems, Westlake, NY), and cells were allowed to incubate in this medium for 4 hours. Enzyme-linked immunosorbent assay. HUC were plated onto 100 mm petri plates in F12+ and incubated at 37 °C overnight. Cells were exposed to test compounds for 24
hours. Whole cell lysates (see immunoblotting) were prepared from individual plates.
Enzyme-linked immunosorbent assay was performed using the Nerve Growth Factor E max
ImmunoAssay System  (Promega) to determine NGF content. Briefly, flat-bottom 96
well plates were coated with anti-NGF polyclonal antibody and incubated for 14-18 hours at 4° C. After 1 hour of incubation with blocking solution, test solution was added and allowed to incubate for 6 hours at room temperature while being shaken. Plates were washed, monoclonal antibody was added, and plates were incubated at 4° C for 14-18
hours. After washing, the amount of bound monoclonal antibody was detected using antibody conjugated to horseradish peroxidase as a tertiary reactant. The unbound conjugate was removed by washing, chromogenic substrate was added, and color change was determined using an EL312e Microplate Reader (Bio-Tek Instruments) at 450 nm.
All samples were run in duplicate on 2 separate occasions, and values were averaged.
Immunocytochemistry. HUC were grown in chamber slides (Lab-Tek) for 12 -24
hour and then rinsed with PBS and fixed in cold acetone. After rinse, background was blocked with 10% normal goat serum for 1 hour at room temperature, and slides were incubated with each antibody overnight at 4° C. Staining was revealed by using a TSA Statistics. Data from immunoblotting and proliferation assays are presented as arithmetic means ± SEM of 6-12 replicates. One-way or two-way analysis of variance (ANOVA) was performed to determine significant differences among one factor or two factors experimental treatments, respectively. Individual groups were compared using Fisher's (Least Significance Difference) test. A p-value of < 0.05 was considered significant.
RESULTS

Effects of rhNGF, E 2 and ICI 182,780 on proliferation of primary cultures of HUC.
rhNGF (100 ng/ml) and E 2 (50 nM) both stimulated HUC proliferation (Figure 1 ; p <0.01, p <0.01, respectively) in a time-dependent manner. The selective ER α agonist, 16I E 2 (10 nM), and genistein (50 nM), which should act as an ER β agonist at this concentration (48), also stimulated proliferation of HUC ( Figure 2 ). Incubation of HUC with 10 -9 M to 10 -6 M of E 2 for 8 hours demonstrated a concentration-dependent effect on proliferation, which was suppressed by the specific estrogen receptor antagonist ICI 182,780 (100 nM, p < 0.01, Figure 3 ). These data provide direct evidence that estrogens stimulate HUC proliferation by activating estrogen receptors.
Estradiol stimulated NGF synthesis and release in primary cultures of HUC.
Incubation of primary HUC with E 2 (1 nM) for 24 hours resulted in a 28% increase in NGF in whole cell lysate (Figure 4 ). ICI 182,780 (100 nM) alone had no effect on NGF content in cell lysate but inhibited estrogen-induced increase in cell lysate NGF content.
These data indicate that estrogen stimulates NGF synthesis by ligand binding to the estrogen receptor.
NGF antiserum and trkA inhibitor specifically block rhNGF-stimulated HUC
proliferation. Incubation of HUC with rhNGF (1-100 ng/ml) for 8 hours increased proliferation in a concentration-dependent manner, and this effect was not affected by non-immune rabbit serum and was completely abolished by NGF antiserum (0.1 µl/ml, p < 0.01, Figure 5A ). K252a (100 nM), a specific trkA phosphorylation inhibitor, inhibited HUC proliferation in the absence of exogenous NGF ( Figure 5B ). This effect suggests the presence of an autocrine/paracrine mechanism in the synthesis and release of NGF by HUC. K252a (100 nM) also suppressed HUC proliferation in response to rhNGF (1-100 ng/ml, p < 0.01, Figure 5B ). The specificity of the response of HUC to NGF was tested by evaluating proliferation of HUC in response to EGF (0.2 ng/ml-20 ng/ml) or PMA (10 nM-1 µM) in the absence or presence of K252a (100 nM) or NGF antiserum (0.1 µl/ml).
Both EGF and PMA increased proliferation in a concentration-dependent manner (Figures 6A and 6B ; p<0.01 and p<0.01, respectively). Neither K252a nor NGF antiserum affected cell proliferation induced by EGF or PMA. These results indicate that NGF-induced HUC proliferation is mediated by the high-affinity receptor for NGF (trkA) and that NGF antiserum is not a nonspecific inhibitor of proliferation.
NGF antiserum and trkA inhibitor block estrogen-stimulated HUC proliferation.
HUC proliferation stimulated by E 2 , 16IE 2 or genistein was abolished by NGF antiserum (0.1 µl/ml) ( Figure 7) . Incubation of HUC with E 2 (10 -9 -10 -6 M) for 8 hours stimulated a concentration-dependent increase in proliferation, and this effect was abolished by K252a
(100 nM, p < 0.01, Figure 8 ). These results indicate that increased HUC proliferation stimulated by estrogen is at least partially mediated by interaction of NGF and trkA.
Expression of ER α , ER β , trkA, and p75 receptors in primary cultures of HUC.
Strong staining of keratin in cytoplasm was observed in each cell, confirming that the cells were of epithelial origin ( Figure 9 ). The networks of cytoskeletal fibers were clearly shown with keratin antibody. Strong staining of ER α and ER β was associated with the nuclei of HUC, and weaker staining was also observed in the cytoplasm. Specific staining of trkA and p75 was observed only in the cytoplasm of HUC. The presence of these receptors in HUC was further confirmed by immunoblotting (data not shown).
Effect of K252a and NGF antiserum on phosphorylation of trkA in primary cultures of HUC.
To study the possible mechanism of NGF-induced HUC proliferation, we assessed the effects of rhNGF and E 2 on tyrosine phosphorylation of trkA. Using a monoclonal antibody for tyrosine phosphorylated trk A, expression of p-trk A after 15 minutes, 30 minutes, and 2 hours incubation of HUC with rhNGF (50 ng/ml) or rhNGF (50 ng/ml) combined with K252a (100 nM) was evaluated ( Figure 10 ). Densitometric analysis revealed a 3-4 fold increase with rhNGF treatments, and this effect was completely inhibited by K252a. E 2 and rhNGF both increased phosphorylation of trkA, which was abolished by K252a or NGF antiserum ( Figure 11 ). We also observed that expression of total trkA was unaffected by these treatments in both experiments ( Figures   10 and 11 ). Reprobing with monoclonal antibody for α-tubulin confirmed equal loading of protein in each preparation.
DISCUSSION
This study addresses the role of NGF in proliferation of HUC in response to estrogen. The data presented here contribute new observations to this area by (20, 21, 22) . p75 may be involved in apoptosis (46), but it has also been shown that p75 increases the affinity of trkA for NGF (4) . Phosphorylation and internalization of trkA leads to activation of second messenger cascades including MAP kinase and PI3 kinase, two pathways important for cell differentiation and survival, respectively The total trkA expression was unchanged, indicating that proliferation of HUC stimulated by NGF involves phosphorylation of trkA.
The interaction of steroid hormones with membrane-associated receptor tyrosine kinase signaling pathways is currently under investigation but is still poorly understood.
There is increasing evidence that reproductive hormones modulate NGF synthesis. In the guinea pig uterus, NGF-protein levels showed no significant change during pregnancy, but showed a marked increase during the early postpartum (9) . In the zebra finch telecephalon, reduced estrogen significantly decreased both trkA and p75, and E 2 treatment increased trkA (13) . Furthermore, Lara et al observed that a single injection of estrogen resulted in increased intraovarian synthesis of NGF and p75 in rats (29). In addition, it has been observed that ER, trkA and p75 are colocalized in a subpopulation of dorsal root ganglion neurons, and E 2 directly upregulated trkA and p75 NGF receptors in a time-and concentration-dependent manner (26) . NGF also significantly enhanced cell survival and reduced cell apoptosis in both ER-expressing and control PC12 cells, but E 2 stimulated a further significant enhancement of cell survival and reduction in apoptosis only in ER-expressing cells. Estrogen treatment was also observed to increase trkA mRNA levels in ER-expressing PC12 cells (15,16). It is therefore quite possible that the synergistic effects of estrogen and NGF operate at the NGF receptor level. In our study, we observed a significant increase in NGF content of HUC in response to E 2 , and this effect was completely abolished by ICI 182,780.
It has been speculated that estrogen may act synergistically with NGF through mechanisms that involve the regulation of EREs (43) . Support for this hypothesis comes from the observation that motifs which mimic classical EREs are found in the promoter and 5'flanking regions of the genes for human NGF, trkA, and p75 (23,44). We tested the possibility that NGF and trkA participate in estrogen-induced HUC proliferation using NGF antiserum and K252a. Either NGF antiserum or K252a abolished HUC proliferation induced by E 2 , 16IE 2, or genistein. Therefore, the effect of ER activation is likely to be NGF and/or trkA related. It should also be noted that NGF was found to increase expression of ER in the developing cerebral cortex and basal forebrain in a posttranscriptional manner, suggesting that NGF may also affect abundance of ER (32, 44 Moreover, we also demonstrate that estrogen stimulates NGF synthesis. Thus, the proliferative effect of estrogen is at least partially mediated by NGF and especially by phosphorylation of the trkA receptor. These findings may have relevance to development or repair of the lining of the urinary tract. Future work will assess signal transduction involved in this mechanism. 
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